Home › Funds › ALERUS FINANCIAL NA › IMNM
ALERUS FINANCIAL NA position in IMNM
IMMUNOME INC · Health Care
ALERUS FINANCIAL NA reported holding 300,000 shares of IMNM (IMMUNOME INC) in its Q3 2026 13F filing — a position valued at US$6.5M, representing 0.28% of its reported portfolio and ranking #46 among its reported holdings. ALERUS FINANCIAL NA has disclosed IMNM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ALERUS FINANCIAL NA's IMNM position evolved
ALERUS FINANCIAL NA first disclosed a stake in IMNM in Q2 2026 at 383,421 shares (US$8.1M). Across 2 filings, ALERUS FINANCIAL NA increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 300,000 shares valued at US$6.5M — a reduction of -83,421 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 383.42K | $8.12M | New |
| Q3 2026 | 300.00K | $6.45M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMNM and 13F data
IMNM (IMMUNOME INC) is a Health Care company. 43 other funds we track also report a position in IMNM — the largest reported positions include Redmile Group, LLC (US$104.1M), Enavate Sciences GP, LLC (US$76.6M), SILVERARC CAPITAL MANAGEMENT, LLC (US$45.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMNM
- Redmile Group, LLC 4.91M sh · $104.08M · Q2 2026
- Enavate Sciences GP, LLC 3.61M sh · $76.58M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 2.09M sh · $45.01M · Q3 2026
- Sofinnova Investments, Inc. 1.72M sh · $36.45M · Q2 2026
- READYSTATE ASSET MANAGEMENT LP 1.61M sh · $34.03M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 732.51K sh · $15.52M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 621.08K sh · $13.36M · Q3 2026
- Parkman Healthcare Partners LLC 594.20K sh · $12.59M · Q2 2026
More on ALERUS FINANCIAL NA
FAQ
How long has ALERUS FINANCIAL NA held IMNM?
ALERUS FINANCIAL NA has disclosed IMNM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is ALERUS FINANCIAL NA's current position in IMNM?
As of Q3 2026, ALERUS FINANCIAL NA holds 300.00K shares of IMNM (IMMUNOME INC), valued at $6.45M, representing 0.28% of its reported portfolio and ranking #46.
Has ALERUS FINANCIAL NA been buying or selling IMNM?
In the latest 13F filing (Q3 2026), ALERUS FINANCIAL NA reduced its position in IMNM.
Which other funds hold IMNM?
Other major institutional holders of IMNM include Redmile Group, LLC, Enavate Sciences GP, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.